Biotech BOOM
As New Jersey stumbled through one of its episodic bouts of dysfunctional state budgeting 
two years ago, the Nevada Development Authority sensed a chance to pounce on a wounded animal. The state’s business recruiting agency launched a $100,000 ad campaign touting Las Vegas’ indulgent business environment, followed by direct mailers to 265 of New Jersey’s biotechnology companies and in-person visits with those that responded. The blitz yielded “serious inquiries” from 40 companies, authority CEO Somer Hollingsworth said at the time, including eight “hard leads” among the prized biotechs. Read full story:
Technorati Tags: TIM O’REILEY, Las Vegas BUSINESS PRESS, Nevada Development Authority, biotechnology, Somer Hollingsworth, David Cantwell, Joseph Cortright, Nevada Cancer Institute, Lou Ruvo Brain Institute, UNLV, John Laub, Regenerative Medicine Organization, Nevada Biotechnology and Bioscience Consortium, Biotechnology Industry Organization, Dr. Ivor Royston, Kevin Klowden, CardioVascular BioTherapeutics, Gautam Jaggi, David Ashley, Dr. Robert Sweitzer, Harry Reid UNLV Research and Technology Park, Bud Pittinger, Dr. Giuseppe Pizzorno, Daniel Montano, NCET, Nevada’s Center for Entrepreneurship and Technology
…